AbbVie (NYSE:ABBV) Issues FY 2024 Earnings Guidance

AbbVie (NYSE:ABBV – Get Free Report) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 10.020-10.060 for the period, compared to the consensus estimate of 10.940. The company issued revenue guidance of -. AbbVie also updated its Q4 2024 guidance to 2.060-2.100 EPS. Wall Street Analysts Forecast […]

Leave a Reply

Your email address will not be published.

Previous post Opinion: 2025 and New York’s Fight Against Child Hunger
Next post Borders & Southern Petroleum (LON:BOR) Trading 39.4% Higher – Time to Buy?